Showing 1 posts of 1 posts found.
Merck is to improve its pipeline of hepatitis C virus (HCV) treatments by splashing out $3.85 billion on biopharma firm …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumentis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera